GoldenGolden
Advanced Search
New Science Ventures

New Science Ventures

New Science Ventures invests in companies in the life sciences and information technology sectors.

New Science Ventures is a venture capital firm which focuses on investments in the life sciences - pharmaceuticals, biologics, medical devices, and diagnostics - and information technology - high-performance semiconductors, cellular infrastructure, sensor networks, enterprise software, and storage - sectors. The firm was founded in 2004 and is based in New York, New York.

New Science Ventures invest in early and late stage companies who they feel have novel scientific approaches to address unmet needs creating improvements in performances. They also invest in companies using science-based innovations to address market needs in life sciences such as pharmaceuticals, biologics, medical devices, diagnostics, and IT. Their team have expertise in strategy and corporate planning, operations and cost management, and leadership development.

Investment

New Science Ventures has made 60 investments. Their most recent investment was on Jul 17, 2019, when DUST Identity raised $10M. Their investments include DUST Identity, PlanetIQ, Paradigm Diagnostics, ISORG, Morrow Optics, ChromaCure, Cambridge Epigenetix, Escalier Biosciences, zeotap, Caringo, BrightVolt, Vuv Analytics, and Kateeva.

Their exited investments include Vaultive, TherOx, Seahorse Bioscience, Celleration, Dezima Pharma, Akarna Therapeutics, Lightwire, BioVex, Ception Therapeutics and FlowCardia.

Funds

New Science Ventures has raised a total of $23.9M in a single venture fund, New Science Ventures Fund III, L.P.. This fund was announced on Jun 16, 2014 and raised a total of $23.9M.

Timeline

Associated investment funds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Phase Four
June 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- Phase Four, the creator of the radio-frequency thruster for satellite propulsion, announced today that it has closed a Series B investment...
New Science Ventures (NSV)
March 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- New Science Ventures LLC ("NSV"), a leading venture capital firm focused on building companies that leverage breakthrough science to create...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.